Worthington Mark (CIK 1861464) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy LONA (5,726 shares), Sell LONA (1,328 shares), Buy ATHA (3,667 shares), Sell ATHA (876 shares), Buy ATHA (36,666 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | LeonaBio, Inc. (LONA) | GENERAL COUNSEL and CCO | Buy | 5,726 | $0 |
| 2026-03-05 | LeonaBio, Inc. (LONA) | GENERAL COUNSEL and CCO | Sell | 1,328 | $7,131 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | General Counsel and CCO | Buy | 3,667 | $0 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | General Counsel and CCO | Sell | 876 | $6,027 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | General Counsel and CCO | Buy | 36,666 | $0 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | General Counsel and CCO | Sell | 8,526 | $2,473 |
Source: SEC Form 4 filings · as of 2026-03-05